Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Aug;13(4):388-94.
doi: 10.1007/s11894-011-0204-x.

Carbohydrate provision in the era of tight glucose control

Keith R Miller  1 , Christy M Lawson, Vance L Smith, Brian G Harbrecht
Affiliations
Review

Carbohydrate provision in the era of tight glucose control

Keith R Miller et al. Curr Gastroenterol Rep. 2011 Aug.

Abstract

Glycemic control in the critically ill patient has remained a controversial issue over the last decade. Several large trials, with widely varying results, have generated significant interest in defining the optimal target for blood-glucose control necessary for improving care while minimizing morbidity. Nutritional support has evolved into an additional area of critical care where appropriate practices have been associated with improved patient outcomes. Carbohydrate provision can impact blood-glucose levels, and the relationship between nutrition and glucose levels has become more complex in the era of improved glycemic control. This review discusses the controversy surrounding intensive-insulin therapy in the intensive care unit and explores the relationship with nutritional support, both in the enteral and parenteral form. Achieving realistic goals in both carbohydrate provision and glycemic control may improve patient outcome, and are not mutually exclusive practices.

PubMed Disclaimer

Conflict of interest statement

Disclosure:

No potential conflicts of interest relevant to this article were reported.

Similar articles

See all similar articles

Cited by

  • Parenteral nutrition-associated hyperglycemia in non-critically ill inpatients increases the risk of in-hospital mortality (multicenter study).
    Olveira G, Tapia MJ, Ocón J, Cabrejas-Gómez C, Ballesteros-Pomar MD, Vidal-Casariego A, Arraiza-Irigoyen C, Olivares J, Conde-García Mdel C, García-Manzanares A, Botella-Romero F, Quílez-Toboso RP, Cabrerizo L, Matia P, Chicharro L, Burgos R, Pujante P, Ferrer M, Zugasti A, Prieto J, Diéguez M, Carrera MJ, Vila-Bundo A, Urgelés JR, Aragón-Valera C, Rovira A, Bretón I, García-Peris P, Muñoz-Garach A, Márquez E, Del Olmo D, Pereira JL, Tous MC; Study Group of Hyperglycemia in Parenteral Nutrition: Nutrition Area of the Spanish Society of Endocrinology and Nutrition (SEEN). Olveira G, et al. Diabetes Care. 2013 May;36(5):1061-6. doi: 10.2337/dc12-1379. Epub 2012 Dec 6. Diabetes Care. 2013. PMID: 23223407 Free PMC article.

References

    1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367. - PubMed
    1. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–461. - PubMed
    1. Pavy FW. Fundamental Points Connected with the Pathology of Diabetes Mellitus. Br Med J. 1900 Dec 1;2(2083):1558–1561. - PMC - PubMed
    1. Turina M, Fry DE, Polk HC., Jr Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005 Jul;33(7):1624–33. - PubMed
    1. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000 Jun 8;67(3):291–300. - PubMed

MeSH terms

Substances